These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33835078)

  • 21. Potent gastric acid inhibition in Helicobacter pylori eradication.
    Gisbert JP
    Drugs; 2005; 65 Suppl 1():83-96. PubMed ID: 16335862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.
    Kuhl A; Odunayo A; Price J; Hecht S; Marshall K; Steiner J; Tolbert MK
    J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of Blastocystis carriage with antimicrobials: reality or delusion?
    Stensvold CR; Smith HV; Nagel R; Olsen KE; Traub RJ
    J Clin Gastroenterol; 2010 Feb; 44(2):85-90. PubMed ID: 19834337
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Gao L; Xia X; Gong X; Zhang H; Sun Y
    Front Cell Infect Microbiol; 2024; 14():1296151. PubMed ID: 38304196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.
    Imhann F; Vich Vila A; Bonder MJ; Lopez Manosalva AG; Koonen DPY; Fu J; Wijmenga C; Zhernakova A; Weersma RK
    Gut Microbes; 2017 Jul; 8(4):351-358. PubMed ID: 28118083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the Human Gut Microbiota Associated With Colonization by
    Even G; Lokmer A; Rodrigues J; Audebert C; Viscogliosi E; Ségurel L; Chabé M
    Front Cell Infect Microbiol; 2021; 11():533528. PubMed ID: 33816323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.
    Akter S; Hassan MR; Shahriar M; Akter N; Abbas MG; Bhuiyan MA
    Alzheimers Res Ther; 2015 Dec; 7():79. PubMed ID: 26714488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.
    Mirza H; Wu Z; Kidwai F; Tan KS
    Infect Immun; 2011 Dec; 79(12):5019-26. PubMed ID: 21930763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between Blastocystis subtype ST4 and gut microbiota in vitro.
    Deng L; Tan KSW
    Parasit Vectors; 2022 Mar; 15(1):80. PubMed ID: 35260166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison tables: H2-receptor antagonists and PPIs.
    Med Lett Drugs Ther; 2022 Apr; 64(1647):e56-e57. PubMed ID: 35348553
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM; Scates AC; Latour JK
    Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity.
    Rajamanikam A; Isa MNM; Samudi C; Devaraj S; Govind SK
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011170. PubMed ID: 36989208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.
    Cussotto S; Strain CR; Fouhy F; Strain RG; Peterson VL; Clarke G; Stanton C; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2019 May; 236(5):1671-1685. PubMed ID: 30155748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characteristics of Blastocystis sp. ST3 at the genome level in the Chinese population.
    Han N; Peng X; Qiang Y; Zhang T; Li X; Zhang W
    Parasitol Res; 2023 Nov; 122(11):2719-2727. PubMed ID: 37715083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
    Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
    Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.